Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development.

Saved in:
Bibliographic Details
Title: Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development.
Authors: Sane RS; Clinical Pharmacology, Genentech, Inc., South San Francisco, California. Electronic address: sane.rucha@gene.com., Mitra P; Department of Clinical Pharmacology & Nonclinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut., Lai Y; Drug Metabolism, Gilead Sciences, Inc, Foster City, California., Li CY; Department of Pharmacokinetics and Drug Metabolism, Amgen Inc, South San Francisco, California., Shen H; Department of Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb Research and Development, Princeton, New Jersey., Tohyama K; Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Costales C; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Salphati L; Departments of Drug Metabolism and Pharmacokinetics, Genentech, Inc, South San Francisco, California., Mahar KM; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania., Bow DAJ; Quantitative, Translational and ADME Sciences, AbbVie Inc, North Chicago, Illinois., Vergis JM; IQ Secretariat, Faegre Drinker Biddle & Reath LLP, Washington, District of Columbia., Brumm J; Nonclinical Biostatistics, Genentech, Inc, South San Francisco, California., Taskar K; DMPK Modeling, IVIVT, Research, GSK, Stevenage, United Kingdom., Chanteux H; Quantitative Clinical Pharmacology, Early Clinical Development & Translational Sciences, UCB Biopharma SRL, Braine-L'Alleud, Belgium., Fang Z; NCE Drug Metabolism and Pharmacokinetics, the Healthcare Business of Merck KGaA, Darmstadt, Germany., Liang X; Drug Metabolism, Gilead Sciences, Inc, Foster City, California., Park SH; Preclinical Sciences and Translational Safety, Johnson & Johnson, Spring House, Pennsylvania., Hanna I; Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, East Hanover, New Jersey., Thakkar N; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania., Chu X; Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co, Inc, Rahway, New Jersey., Hop CECA; Departments of Drug Metabolism and Pharmacokinetics, Genentech, Inc, South San Francisco, California., Rollison HE; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Taub ME; Department of Clinical Pharmacology & Nonclinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut., Kimoto E; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Fenner KS; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Xu C; Pharmacokinetics, Dynamics, and Metabolism, Translational Medicine and Early Development, Sanofi US, Bridgewater, New Jersey., Hillgren KM; Investigative Drug Disposition, Lilly Research Laboratories, Eli Lilly Inc, Indianapolis, Indiana.
Source: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2026 Apr; Vol. 54 (4), pp. 100255. Date of Electronic Publication: 2026 Feb 24.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41894930
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sane+RS%22">Sane RS</searchLink>; Clinical Pharmacology, Genentech, Inc., South San Francisco, California. Electronic address: sane.rucha@gene.com.<br /><searchLink fieldCode="AU" term="%22Mitra+P%22">Mitra P</searchLink>; Department of Clinical Pharmacology & Nonclinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut.<br /><searchLink fieldCode="AU" term="%22Lai+Y%22">Lai Y</searchLink>; Drug Metabolism, Gilead Sciences, Inc, Foster City, California.<br /><searchLink fieldCode="AU" term="%22Li+CY%22">Li CY</searchLink>; Department of Pharmacokinetics and Drug Metabolism, Amgen Inc, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Shen+H%22">Shen H</searchLink>; Department of Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb Research and Development, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Tohyama+K%22">Tohyama K</searchLink>; Takeda Pharmaceutical Company Limited, Fujisawa, Japan.<br /><searchLink fieldCode="AU" term="%22Costales+C%22">Costales C</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Salphati+L%22">Salphati L</searchLink>; Departments of Drug Metabolism and Pharmacokinetics, Genentech, Inc, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Mahar+KM%22">Mahar KM</searchLink>; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Bow+DAJ%22">Bow DAJ</searchLink>; Quantitative, Translational and ADME Sciences, AbbVie Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Vergis+JM%22">Vergis JM</searchLink>; IQ Secretariat, Faegre Drinker Biddle & Reath LLP, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Brumm+J%22">Brumm J</searchLink>; Nonclinical Biostatistics, Genentech, Inc, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Taskar+K%22">Taskar K</searchLink>; DMPK Modeling, IVIVT, Research, GSK, Stevenage, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chanteux+H%22">Chanteux H</searchLink>; Quantitative Clinical Pharmacology, Early Clinical Development & Translational Sciences, UCB Biopharma SRL, Braine-L'Alleud, Belgium.<br /><searchLink fieldCode="AU" term="%22Fang+Z%22">Fang Z</searchLink>; NCE Drug Metabolism and Pharmacokinetics, the Healthcare Business of Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Drug Metabolism, Gilead Sciences, Inc, Foster City, California.<br /><searchLink fieldCode="AU" term="%22Park+SH%22">Park SH</searchLink>; Preclinical Sciences and Translational Safety, Johnson & Johnson, Spring House, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hanna+I%22">Hanna I</searchLink>; Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, East Hanover, New Jersey.<br /><searchLink fieldCode="AU" term="%22Thakkar+N%22">Thakkar N</searchLink>; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Chu+X%22">Chu X</searchLink>; Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co, Inc, Rahway, New Jersey.<br /><searchLink fieldCode="AU" term="%22Hop+CECA%22">Hop CECA</searchLink>; Departments of Drug Metabolism and Pharmacokinetics, Genentech, Inc, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Rollison+HE%22">Rollison HE</searchLink>; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Taub+ME%22">Taub ME</searchLink>; Department of Clinical Pharmacology & Nonclinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut.<br /><searchLink fieldCode="AU" term="%22Kimoto+E%22">Kimoto E</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Fenner+KS%22">Fenner KS</searchLink>; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Xu+C%22">Xu C</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Translational Medicine and Early Development, Sanofi US, Bridgewater, New Jersey.<br /><searchLink fieldCode="AU" term="%22Hillgren+KM%22">Hillgren KM</searchLink>; Investigative Drug Disposition, Lilly Research Laboratories, Eli Lilly Inc, Indianapolis, Indiana.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229421550%22">Drug metabolism and disposition: the biological fate of chemicals</searchLink> [Drug Metab Dispos] 2026 Apr; Vol. 54 (4), pp. 100255. <i>Date of Electronic Publication: </i>2026 Feb 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Pharmacology+and+Experimental+Therapeutics%2C+etc%2E]%22">American Society for Pharmacology and Experimental Therapeutics, etc.] </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9421550 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-009X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200909556%22">00909556 </searchLink><i>NLM ISO Abbreviation: </i>Drug Metab Dispos <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41894930
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.dmd.2026.100255
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100255
    Titles:
      – TitleFull: Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sane RS
      – PersonEntity:
          Name:
            NameFull: Mitra P
      – PersonEntity:
          Name:
            NameFull: Lai Y
      – PersonEntity:
          Name:
            NameFull: Li CY
      – PersonEntity:
          Name:
            NameFull: Shen H
      – PersonEntity:
          Name:
            NameFull: Tohyama K
      – PersonEntity:
          Name:
            NameFull: Costales C
      – PersonEntity:
          Name:
            NameFull: Salphati L
      – PersonEntity:
          Name:
            NameFull: Mahar KM
      – PersonEntity:
          Name:
            NameFull: Bow DAJ
      – PersonEntity:
          Name:
            NameFull: Vergis JM
      – PersonEntity:
          Name:
            NameFull: Brumm J
      – PersonEntity:
          Name:
            NameFull: Taskar K
      – PersonEntity:
          Name:
            NameFull: Chanteux H
      – PersonEntity:
          Name:
            NameFull: Fang Z
      – PersonEntity:
          Name:
            NameFull: Liang X
      – PersonEntity:
          Name:
            NameFull: Park SH
      – PersonEntity:
          Name:
            NameFull: Hanna I
      – PersonEntity:
          Name:
            NameFull: Thakkar N
      – PersonEntity:
          Name:
            NameFull: Chu X
      – PersonEntity:
          Name:
            NameFull: Hop CECA
      – PersonEntity:
          Name:
            NameFull: Rollison HE
      – PersonEntity:
          Name:
            NameFull: Taub ME
      – PersonEntity:
          Name:
            NameFull: Kimoto E
      – PersonEntity:
          Name:
            NameFull: Fenner KS
      – PersonEntity:
          Name:
            NameFull: Xu C
      – PersonEntity:
          Name:
            NameFull: Hillgren KM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1521-009X
          Numbering:
            – Type: volume
              Value: 54
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Drug metabolism and disposition: the biological fate of chemicals
              Type: main
ResultId 1